Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9,967 JPY | +0.73% | +0.06% | -22.89% |
03-06 | Shares in Japan's Ain soar after activist fund Oasis buys 9.6% stake | RE |
02-28 | Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- 2nd Update | DJ |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.43 for the 2024 fiscal year.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company does not generate enough profits, which is an alarming weak point.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-22.89% | 3.07B | D | ||
-10.65% | 3.64B | D+ | ||
+1.28% | 3.38B | D- | ||
+7.42% | 2.68B | - | ||
+11.98% | 2.65B | C+ | ||
-7.95% | 1.76B | - | ||
+11.42% | 1.35B | - | - | |
-19.60% | 984M | - | ||
-37.98% | 707M | - | - | |
-0.53% | 454M | - | D+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 3391 Stock
- Ratings Tsuruha Holdings Inc.